Dr. Razieh Soltani Arabshahi, MD

Dr. Soltani Arabshahi practices at Pasedena Laser & Surgery Center in Pasadena, California.

Dr. Soltani Arabshahi's NPI, 1033423413, was assigned on July 28, 2010. Dr. Soltani Arabshahi graduated from Tehran University of Medical Sciences School of Medicine in 2002. Dr. Soltani Arabshahi's California license number on file is 35.123120.

Dr. Soltani Arabshahi's primary practice is Pasedena Laser & Surgery Center, at 960 E Green St, Pasadena, CA 91106 in Los Angeles County. The practice phone is (626) 294-4866.

Dr. Soltani Arabshahi's primary practice is Pasedena Laser & Surgery Center in Pasadena, California. Dr. Soltani Arabshahi is also affiliated with Huntington Hospital. The medical group on file is Pasadena Premier Dermatology. Dmand AI also links Dr. Soltani Arabshahi to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Soltani Arabshahi practices, 3 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Soltani Arabshahi's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Soltani Arabshahi is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Soltani Arabshahi's licenses on file in 3 states: California, Ohio and Utah.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, facial skin infection, hives and itchy rashes among the conditions Dr. Soltani Arabshahi treats.

CMS data shows 3,645 Medicare services from Dr. Soltani Arabshahi across 28 procedure codes in 2024, for 786 Medicare patients. Medicare paid $388,731 for them. Every service was in an office.

CMS counts 786 Medicare patients who saw Dr. Soltani Arabshahi in 2024. The largest group is 65 to 74, with 342 patients. 75% of them have high cholesterol, and 67% have high blood pressure. Their average risk score is 0.90, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Soltani Arabshahi's median patient age at 72, with 53% women.

In 2024, Dr. Soltani Arabshahi wrote 664 Medicare Part D claims for 326 patients. 94% of them were for generic drugs. CMS names the drug for 549 of them, across 18 drugs with 11 or more claims each, at $113,259 in total drug cost. In 2023, CMS named 485 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Soltani Arabshahi for performance year 2024, reported individually. Dr. Soltani Arabshahi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 441 procedures of skin biopsy by Dr. Soltani Arabshahi, more than 94% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Soltani Arabshahi, published from 2008 to 2011. Dr. Soltani Arabshahi's most frequent co-authors are Jennifer Belasco, MD, Gerald G. Krueger, MD and James Krueger, MD, PhD.

Dmand AI links Dr. Soltani Arabshahi to 1 clinical trial. Conditions studied include Psoriasis and Skin Diseases, Papulosquamous.

CMS Open Payments shows 257 general payments to Dr. Soltani Arabshahi from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Sanofi and Genzyme US Companies paid the most, $1,313.

Dmand AI lists 4 awards for Dr. Soltani Arabshahi, most recently Teacher of the year in dermatologic surgery in 2016.

Dr. Soltani Arabshahi graduated from Tehran University of Medical Sciences School of Medicine in 2002. Dr. Soltani Arabshahi is a member of AAD, American College of Mohs Surery, ASDS, International Dermatology Society and International Peeling Society.

Dr. Soltani Arabshahi is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.